| No. | Technology | Agreement date |
|---|---|---|
| 1 | Two types of kimchi lactic acid bacteria with anti-obesity and immune-enhancing activities at the same time | Jun.28.2021 |
| It relates to Lactobacillus ali WiKim39 and Lactococcus lactis WiKim0124 separated from kimchi, and two types of lactic acid bacteria that can be used as food and pharmaceuticals for the prevention and improvement of obesity or immunity enhancement use were transferred to Company S. | ||
| 2 | Leuconostoc mesenteroides WiKim33 strain and kimchi manufacturing method using the same | Sep.13.2021 |
| As a kimchi lactic acid bacterium that can be used as a kimchi starter due to its high survival rate and high mannitol production in the environment of kimchi, when kimchi was manufactured using WiKim33, the rate of increase in acidity was slower(28 days extension compared to control group) than that of kimchi without the addition of starter, and it was transferred to company E with a technology that improved kimchi quality such as improvement of sensory characteristics(carbonated sense, clean taste, cool taste). | ||
| 3 | Kimchi starter, Leuconostoc mesenteroides WiKim33 Optimal Production Process Technology | Sep.13.2021 |
| As an optimal production condition for self-cultivating kimchi starter WiKim33, it produces kimchi starter WiKim33 with high and stable efficiency, and then kimchi starter WiKim33, in the condition that Kimchi starter activity is superior to that of freeze-dried powder, was transferred to company E with a technology which can be added to kimchi. | ||
| 4 | Prevention and improvement of cancer, 4 types of microorganisms | Sep.17.2021 |
| It relates to the development of cancer treatment technology with increased biosafety and anti-tumor efficiency by using non-toxic kimchi lactic acid bacteria including WiKim0129, WiKim0130, WiKim0132, and WiKim0133, technology that can be used in other fields such as high added value creation and biomedical field, etc. was transferred to Company L. | ||
| 5 | Kimchi Lactobacillus MGBi0010 | Oct.10.2021 |
| It relates to the Kimchi lactic acid bacteria distributed through the Microbial Gene Bank biological resource distribution system operated by the World Institute of Kimchi, it was transferred to Company G for the development of various uses of Kimchi lactic acid bacteria. | ||
* Contact: Future Strategy Group (+82-62-610-1835, jiseok@wikim.re.kr)